Ulcerative colitis and Crohn's disease are inflammatory bowel diseases with a chronic
relapsing course. Management of both conditions is far from being fully satisfactory. For this …

Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

The etiology of inflammatory bowel disease (IBD) is not completely understood, thus current
therapies have been empirical and directed at treating symptoms rather than addressing the …

Ulcerative colitis (UC) and Crohn's disease (CD) are debilitating idiopathic inflammatory
bowel diseases (IBDs) with symptoms that impair ability to function and quality of life. The …

Inflammatory bowel disease (IBD) is frequently associated with the infiltration of a large
number of leukocytes into the bowel mucosa. Therefore, the removal of circulating …

Ulcerative colitis (UC) and Crohn's disease (CD) are the major forms of idiopathic
inflammatory bowel disease (IBD). Both UC and CD are debilitating chronic disorders that …

Cytokines such as TNF-α have a validated role in the immunopathogensis of ulcerative
colitis (UC), and intercepting inflammatory cytokines is currently the best option for …

Background Patients with UC and CD, characterized by elevations in peripheral blood
granulocytes, monocytes/macrophages, and proinflammatory mediators, may benefit from …

Ulcerative colitis (UC) and Crohn's disease (CD) are major phenotypes of the chronic
inflammatory bowel disease (IBD), which afflicts millions of individuals throughout the world …

Inflammatory and/or autoimmune diseases like ulcerative colitis (UC) or Crohn's disease
(CD) are debilitating chronic disorders that poorly respond to pharmacological interventions …